Current Use of Methylprednisolone for Acute Spinal Cord Injury by Spine Surgeons of Thailand

Authors

  • Panya Luksanapruksa Department of Orthopedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700

Keywords:

Methylprednisolone, acute spinal cord injury, Thailand, survey

Abstract

Objective: To determine current decision making in methylprednisolone succinate (MPS) administration for acute spinal cord injury (ASCI) treatment in Thailand.
Methods:A questionnaire was sent to all orthopedic surgeons who attended the annual meeting of the Spine Society of Thailand 2016. The questionnaire had 3 parts of questions including demographic data, opinions in MPS use in general ASCI patients and patients who meet the exclusion criteria in NASCIS III study.
Results:Fifty-five respondents completed the survey (overall response rate was 27.1 %) and there was 78.18% prescribe MPS to ASCI patients. Among them, 40 % prescribe according to NASCIS II and 55.6% NASCIS III. The main reasons for MPS administration are practice standard (38.6%), effectiveness (31.8%) and liability issue (22.7%). In patients who met the exclusion criteria of NASCIS III, most respondents do not prescribe any steroids in patients who had age below 14 years old (42.2%), pregnancy (77.8%), severe underlying disease (72.7%), body weight more than 109 kg (40.9%), gunshot injury (59.1%) and previous spinal cord injury (46.5%). Interestingly, there were 93.2% prescribed MPS to patients who sustained ACSI more than 8 hours.
Conclusion:Because the institutional standard supported MPS use, most participants prescribed MPS in ASCI despite current clinical data from recent studies. Most participants who did not use MPS in patients had exclusion criteria of NASCIS III.

Downloads

Published

15-08-2016

How to Cite

Luksanapruksa, P. (2016). Current Use of Methylprednisolone for Acute Spinal Cord Injury by Spine Surgeons of Thailand. Siriraj Medical Journal, 68(4), 224–228. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/64482

Issue

Vol. 68 No. 4 (2016): July-August

Section

Original Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.